Kelly Morgan

Kelly Morgan is a seasoned legal professional with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as Senior Vice President at Ring Therapeutics since September 2024, Morgan previously held the position of Senior Vice President, Head of Legal and Corporate Secretary at Arbor Biotechnologies from September 2019 to September 2024. Additional roles include Counsel at Flagship Pioneering, Associate at Saul Ewing LLP, Patent Agent at Pepper Hamilton LLP, and Technical Specialist at Nutter McClennen & Fish LLP. Morgan began a career in research as a Research Fellow at Brigham and Women's Hospital and a Research Assistant at the University of Minnesota. Academic credentials include a Juris Doctor degree in Intellectual Property Law from Suffolk University Law School, a Ph.D. in Microbiology, Immunology, and Molecular Pathobiology, and a Bachelor of Science in Biology from the University of Minnesota.